共 50 条
- [1] Pathologic Features of Renal Carcinoma Following Anti-PD1 Therapy. A Clinicopathologic Analysis of 12 Cases[J]. MODERN PATHOLOGY, 2017, 30 : 254A - 254ASamdani, RashmiRao, Priya
- [2] A multicenter analysis of melanoma recurrence following adjuvant anti-PD1 therapy.[J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)Owen, Carina N.Larkin, James M. G.Shoushtari, Alexander NoorCarlino, Matteo S.Blank, Christian U.Lee, BelindaMangana, JoannaAtkinson, VictoriaMillward, MichaelZaman, FarzanaYoung, ArissaKhattak, Muhammad AdnanPatel, Sapna PradyumanHoeller, ChristophHersey, PeterChauhan, DharmishaPalmieri, David JamesLo, SerigneMenzies, Alexander M.Long, Georgina V.
- [3] CLINICAL, PATHOLOGIC AND GENOMIC PROFILES OF EXCEPTIONAL RESPONDERS TO ANTI-PD1 THERAPY IN RENAL CELL CARCINOMA[J]. JOURNAL OF UROLOGY, 2016, 195 (04): : E19 - E19Ball, MarkJohnson, MichaelGorin, MichaelRodriguez, MariaZhang, MingPapadopoulos, NickHaffner, MichaelHammers, HansMarchionni, LuigiNetto, GeorgeDrake, CharlesAllaf, Mohamad
- [4] Clinical, pathologic and genomic profiles of exceptional responders to anti-PD1 therapy in renal cell carcinoma[J]. BJU INTERNATIONAL, 2015, 116 : 3 - 3Ball, MarkJohnson, MichaelGorin, MichaelRodriguez, MariaDiaz, LuisVogelstein, BertKinzler, KennethPapadopoulos, NickHaffner, MichaelMarchionni, LuigiNetto, GeorgeDrake, CharlesAllaf, Mohamad
- [5] Clinical, pathologic, and genomic profiles of exceptional responders to anti-PD1 therapy in renal cell carcinoma.[J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)Ball, Mark WayneJohnson, Michael HiroshiGorin, Michael A.Rodriguez, MariaDiaz, Luis A.Haffner, MichaelNetto, George J.Drake, Charles G.Allaf, Mohamad E.
- [6] Two cases of granuloma annulare under anti-PD1 therapy[J]. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2018, 145 (02): : 116 - 119Charollais, R.Aubin, F.Roche-Kubler, B.Puzenat, E.
- [7] Clinical analysis of patients (pts) with Lung cancer treated with anti-PD1/PDL1 therapy.[J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)Tian, KaihuaWang, Xintong
- [8] Management of melanoma recurrence following adjuvant anti-PD1 therapy[J]. ANNALS OF ONCOLOGY, 2018, 29Owen, C.Palmieri, D.Guminski, A.Carlino, M. S.Menzies, A. M.Long, G. V.
- [9] Molecular markers of response to anti-pd1 therapy in advanced hepatocellular carcinoma[J]. JOURNAL OF HEPATOLOGY, 2021, 75 : S521 - S522Haber, PhilippTorres-Martin, MiguelAndreu-Oller, CarmenPuigvehi, MarcMaeda, MihoCastet, FlorianRadu, PompiliaDufour, Jean-FrancoisVerslype, ChrisCzauderna, CarolinMarquardt, Jens U.Galle, PeterVogel, ArndtBathon, MelanieMeyer, TimLabgaa, IsmailDigkilia, AntoniaRoberts, LewisAli, Mohamed A. MohamedMinguez, BeatrizCitterio, DavideMazzaferro, VincenzoFinkelmeier, FabianTrojan, JoergOezdirik, BurcinMueller, TobiasSchmelzle, MoritzBejjani, AnthonyFinn, RichardThung, Swan N.Villanueva, AugustoSia, DanielaLlovet, Josep M.
- [10] Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma[J]. GASTROENTEROLOGY, 2023, 164 (01) : 72 - 88.e18Haber, Philipp K.Castet, FlorianTorres-Martin, MiguelAndreu-Oller, CarmenPuigvehi, MarcMiho, MaedaRadu, PompiliaDufour, Jean-FrancoisVerslype, ChrisZimpel, CarolinMarquardt, Jens U.Galle, Peter R.Vogel, ArndtBathon, MelanieMeyer, TimLabgaa, IsmailDigklia, AntoniaRoberts, Lewis R.Ali, Mohamed A. MohamedMinguez, BeatrizCitterio, DavideMazzaferro, VincenzoFinkelmeier, FabianTrojan, JoergOzdirik, BurcinMueller, TobiasSchmelzle, MoritzBejjani, AnthonySung, Max W.Schwartz, Myron E.Finn, Richard S.Thung, SwanVillanueva, AugustoSia, DanielaLlovet, Josep M.